...engineered proteins with antibody-like ligand binding properties. Fund watch Tullis-Dickerson raised $122 million for its Tullis-Dickerson Capital Focus III...
...engineered proteins with antibody-like ligand binding properties. Fund watch Tullis-Dickerson raised $122 million for its Tullis-Dickerson Capital Focus III...